NCT01738373View on ClinicalTrials.gov

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

CompletedOBSERVATIONAL
Enrollment

262

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Bone Marrow / Autologous Transplants
Interventions
DRUG

Plerixafor

Plerixafor will be prescribed independently by the physician, according to usual practice.

Trial Locations (1)

Unknown

Marseille

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT01738373 - Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation | Biotech Hunter | Biotech Hunter